GDHG
GOLDEN HEAVEN GROUP HOLDINGS LTD.
$1.74
+6.10%
$82.0M
No data for this timeframe.
Vol
Market Cap$82.0M
Cap SizeMicro Cap
SEC Reports2
Exchange Nasdaq·Sector Services-Miscellaneous Amusement & Recreation·Inc. E9·CIK 0001928340·Prev Close $1.64
Recent Activity
May 22, 2026
SEC
The SEC declared effective Golden Heaven Group Holdings Ltd.'s F-3 shelf registration (File No. 333-295337) on May 21, 2
EFFECT — Impact 5/10
May 19, 2026
SEC
Golden Heaven Group Holdings completed an internal restructuring with no material change to its business. The 6-K filing
6-K — Impact 2/10
Latest Reports
BEARISH
EFFECT
5/10
The SEC declared effective Golden Heaven Group Holdings Ltd.'s F-3 shelf registration (File No. 333-295337) on May 21, 2
May 22, 2026
NEUTRAL
6-K
2/10
Golden Heaven Group Holdings completed an internal restructuring with no material change to its business. The 6-K filing
May 19, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 1 neutral. Avg impact: 3.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.